ALKERMES



Ebitda Veränderung Datum
AbbVie USD 6.92B 258M 2024-12
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
ALKERMES USD 163.42M 40.22M 2024-12
Amgen USD 3.71B 265M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Gilead Sciences USD 3.21B 651M 2024-12
Intra Cellular Therapies USD -29088000 9.62M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
J&J USD 6.12B 1.51B 2024-12
Malin Corporation EUR -1300000 900K 2024-06
Merck USD 7.12B 1.06B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Otsuka Holdings JPY 92.45B 73.9B 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



ALKERMES - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.